Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konrad Talbot

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Nature Medicine|June 13, 2006
Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophreniaChang-Gyu Hahn, Hoau-Yan Wang, Dan-Sung Cho, et al.
The Journal of Clinical Investigation|May 5, 2004
Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophreniaKonrad Talbot, Wess L Eidem, Caroline L Tinsley, et al.
The Journal of Clinical Investigation|April 6, 2012
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive declineKonrad Talbot, Hoau-Yan Wang, Hala Kazi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 18, 2016
Dysregulation of Specialized Delay/Interference-Dependent Working Memory Following Loss of Dysbindin-1A in Schizophrenia-Related PhenotypesEmilie I Petit, Zuzanna Michalak, Rachel Cox, et al.
The Journal of Clinical Investigation|April 6, 2012
An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomersTheresa R Bomfim, Leticia Forny-Germano, Luciana B Sathler, et al.
Nature Neuroscience|September 27, 2016
Gene expression elucidates functional impact of polygenic risk for schizophreniaMenachem Fromer, Panos Roussos, Solveig K Sieberts, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Nature Medicine|June 13, 2006
Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophreniaChang-Gyu Hahn, Hoau-Yan Wang, Dan-Sung Cho, et al.
The Journal of Clinical Investigation|May 5, 2004
Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophreniaKonrad Talbot, Wess L Eidem, Caroline L Tinsley, et al.
The Journal of Clinical Investigation|April 6, 2012
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive declineKonrad Talbot, Hoau-Yan Wang, Hala Kazi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 18, 2016
Dysregulation of Specialized Delay/Interference-Dependent Working Memory Following Loss of Dysbindin-1A in Schizophrenia-Related PhenotypesEmilie I Petit, Zuzanna Michalak, Rachel Cox, et al.
The Journal of Clinical Investigation|April 6, 2012
An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomersTheresa R Bomfim, Leticia Forny-Germano, Luciana B Sathler, et al.
Nature Neuroscience|September 27, 2016
Gene expression elucidates functional impact of polygenic risk for schizophreniaMenachem Fromer, Panos Roussos, Solveig K Sieberts, et al.
Pageof 4